Find stats on top websites
Ascendis Pharma is a global biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases and oncology. They leverage their proprietary TransCon technology platform to create best-in-class drug candidates. The company is committed to improving patients' lives by addressing unmet medical needs.
Company : Ascendis Pharma
Industry : BiopharmaceuticalsEndocrinologyOncology
Ascendis Pharma Key Value propositions
Ascendis Pharma Latest news
Ascendis Pharma: Patients. Science. Passion.
Investors & News · Terms of Use · Privacy Policy · Cookie Statement. SHARE. LinkedIn ... show top. You are about to access www.ascendispharma.us, which includes ...
Ascendis Pharma: Investors & News
Ascendis Pharma is applying our innovative TransCon™ technologies to build a leading, fully integrated biopharmaceutical company ...
Ascendis Pharma: We've got making a difference for patients down ...
NEWS RELEASES. June 24, 2024. Data from Phase 2 ACcomplisH Trial of TransCon ... show top. You are about to access www.ascendispharma.com. Click below if you ...
Ascendis Pharma A/S Announces U.S. Food and Drug ...
Aug 25, 2021 ... ... important not only for height but also for a child's overall endocrine ... News section of the Ascendis Pharma website at www.ascendispharma.com.
Ascendis Pharma SWOT Analysis
Strengths
Proprietary TransCon technology platformStrong pipeline of drug candidates for rare diseases and oncologyExperienced leadership team with a proven track record
Weaknesses
Dependence on the success of a limited number of drug candidatesRelatively small commercial footprint compared to larger pharmaceutical companiesHigh R&D expenses
Opportunities
Expanding indications for existing drug candidatesStrategic partnerships and collaborationsGrowing demand for rare disease and oncology treatments
Threats
Competition from other biopharmaceutical companiesRegulatory hurdles and potential setbacks in clinical trialsReimbursement challenges and pricing pressures
Top Marketing Strategies for Ascendis Pharma
Ascendis Pharma User Persona
Name:
Age :
Gender :
Occupation :
Industry :
Education :
Preferred platforms
GOALS
Frustrations
Ascendis Pharma Geographic and Demographic Insights
Geographic Insights: The United States is the largest market with 45% of users, followed by Germany and Denmark. The company has a strong presence in North America and Europe.
United States
45%
Germany
15%
Denmark
10%
United Kingdom
8%
France
7%
Demographic Insights: The target audience consists of mostly users aged 35-64, with a slightly higher representation of females. This aligns with the prevalence of targeted diseases.
Ascendis Pharma Socio-economic Profile
Household and Income Insights: Target users are primarily in households of 2-4 people, reflecting typical family structures. The income distribution suggests a mix of middle and high-income earners.
Educational and Employment Insights: The majority of users are employed full-time and possess a university or college degree. This indicates a highly educated and professionally active user base.
Ascendis Pharma Behavioral Insights
Interest-Based Insights: Target users show strong interest in medical research, healthcare innovation, rare diseases, oncology, biotechnology, pharmaceutical news, and patient advocacy.
Technology and Social Media Usage: Users primarily engage through LinkedIn, YouTube, and Twitter, preferring desktop devices. This aligns with their professional profiles.
Ascendis Pharma Top Competitors
Competitor | Estimated market share | Top domains |
---|---|---|
Ipsen | 20% | Endocrinology, Rare Diseases, Neuroscience |
Novo Nordisk | 35% | Diabetes Care, Obesity, Hemophilia |
Pfizer | 25% | Oncology, Vaccines, Rare Diseases |